- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04499560
The Effects of a Nutrition Supplement on Health Related Quality of Life
February 25, 2021 updated by: Jessie Hawkins, PhD, Franklin Health Research
The purpose of this study is to evaluate the health related benefits of a superfoods nutrition supplement on health related quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
After being informed about the study, participants will provide informed consent and be randomized to one of two groups: intervention or control.
Those in the intervention group will consume two ounces of a superfoods drink each morning for 60 days.
Outcomes will be assessed at baseline, on day 30 and on day 60.
Study Type
Interventional
Enrollment (Actual)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Franklin, Tennessee, United States, 37067
- Franklin School of Integrative Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- otherwise healthy
- adults living in the US
- is practicing adequate contraception or is abstaining from all activities which could result in pregnancy
- understands and agrees to comply with study procedures
- provides informed consent
Exclusion Criteria:
- smoker
- pregnant or may become pregnant
- currently breastfeeding
- currently taking antioxidant supplements
- underlying chronic health conditions
- COVID-19 diagnosis
- demonstrated inability to comply with study procedures
- history of allergy to citrus or berry fruits
- has participated in an interventional clinical study within 31 days prior to enrollment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention
Participants consume 2 ounces of the supplement each morning for 60 days.
|
Superfoods based nutritional supplement
|
NO_INTERVENTION: Control
Participants do not make any changes to their health related routines
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in sleep quality on Pittsburgh Sleep Quality Index (PSQI) on Day 60
Time Frame: Baseline and day 60
|
The PSQI is a validated, self reporting instrument assessing sleep.
Possible scores range from 0 to 21 with higher scores indicating lower quality sleep.
The instrument contains 19 items.
|
Baseline and day 60
|
Change from baseline in general wellbeing on the Physical Health Questionnaire (PHQ) on Day 60
Time Frame: Baseline and day 60
|
The PHQ is a validated, self reporting instrument assessing general wellbeing through sleep, respiratory health, headache, and gastrointestinal symptoms.
Possible scores on each item range from 1 to 7 with higher scores indicating greater frequency of symptoms.
The instrument contains 14 items.
|
Baseline and day 60
|
Change from baseline in cognitive wellness on the Self Report Measure of Cognitive Abilities (SRMCA) on Day 60
Time Frame: Baseline and day 60
|
The SRMCA is a validated, self reporting instrument assessing cognitive wellbeing.
Possible scores range from 0 to 27 with higher scores indicating greater cognitive wellbeing.
The instrument contains 44 items.
|
Baseline and day 60
|
Number of days with any cold symptoms as defined by the Jackson Symptom Score on day 60.
Time Frame: Day 60
|
The Jackson Symptom Score is a validated, self reporting instrument which contains 8 cold and flu symptoms.
Scores range from 0 (no symptoms) to 8 (every one of the listed symptoms.)
|
Day 60
|
Change from baseline in stress on the Perceived Stress Scale (PSS) on Day 60
Time Frame: Baseline and Day 60
|
The PSS is a validated, self reporting instrument assessing perceived stress.
Possible scores range from 0 to 40 with higher scores indicating higher stress levels.
The instrument contains ten items.
|
Baseline and Day 60
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 3, 2020
Primary Completion (ACTUAL)
December 31, 2020
Study Completion (ACTUAL)
December 31, 2020
Study Registration Dates
First Submitted
July 30, 2020
First Submitted That Met QC Criteria
August 3, 2020
First Posted (ACTUAL)
August 5, 2020
Study Record Updates
Last Update Posted (ACTUAL)
February 26, 2021
Last Update Submitted That Met QC Criteria
February 25, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-7-1100
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Assistance Publique - Hôpitaux de ParisCompletedDigestive InflammationFrance
-
Pamukkale UniversityCompletedPeriodontal InflammationTurkey
-
Universidade Federal do ParaCompleted
-
KLE Society's Institute of Dental SciencesCompletedRegenerative InflammationIndia
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Oral Science International Inc.AdvarraNot yet recruiting
Clinical Trials on Supplement Drink
-
Nanyang Technological UniversityRecruitingExercise PerformanceSingapore
-
Nutricia UK LtdSuspended
-
Taipei Medical UniversityMeiji Co., Ltd.CompletedMalnutrition ElderlyTaiwan
-
University of VermontCompletedExercise-induced Delayed Onset Muscle SorenessUnited States
-
Maastricht University Medical CenterNutricia ResearchRecruitingPulmonary Disease, Chronic ObstructiveNetherlands
-
Fresenius KabiCompleted
-
Chef V, LLCCitruslabsCompletedDetoxificationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnClinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 | Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8 | Pathologic Stage IIIA Esophageal Adenocarcinoma... and other conditionsUnited States
-
Maastricht University Medical CenterDSM Food SpecialtiesRecruitingProtein Metabolism DisorderNetherlands
-
Maastricht University Medical CenterDSM Food SpecialtiesRecruiting